Periostin Levels do not Distinguish Chronic Obstructive Pulmonary Disease Patients With Frequent and Infrequent Exacerbations
Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2016, Vol 3, Issue 2
Abstract
Background Periostin, an extracellular matrix protein, is involved in inflammatory processes of the lung. To date, most studies have focused on periostin in asthma patients, its role in chronic obstructive pulmonary disease (COPD) is less clear and no information has been reported on blood levels of periostin in COPD patients in the context of exacerbation rates. As such, this exploratory study aimed to investigate whether periostin is helpful to distinguish between COPD patients with frequent and infrequent exacerbations. Methods We performed an examination of patients with COPD participating in a COPD cohort study in Switzerland. Periostin levels were determined in serum samples by using a commercially available enzyme-linked immunosorbent assay (ELISA) kit. Patients underwent evaluation of clinical symptoms including exacerbation rate (exacerbation defined by requiring oral corticosteroids and/or antibiotics) and lung function. In a subgroup of patients an annual follow-up was available that was considered in an additional analysis. Results Twenty six patients (global initiative of obstructive lung disease (GOLD) stage 1 none, 31% stage 2, 38% stage 3, 31% stage 4) were included in the analysis. The mean±standard deviation (SD) age of the patients was 63±5.9 years, 16 were males, 24 were smokers or exsmokers. The median (quartiles) post-bronchodilator FEV1% predicted was 36(27/57). There was no significant difference in periostin levels between patients with frequent and infrequent exacerbations. The follow-up data revealed no evidence that periostin is helpful in distinguishing frequent from infrequent exacerbators. Conclusion Our analysis performed in a small group of carefully matched COPD patients demonstrates that there is no significant relationship between exacerbation rate and periostin levels in blood.
Authors and Affiliations
Christian F. Clarenbach
Keywords
Related Articles
- EP ID EP546558
- DOI 10.17140/PRRMOJ-3-129
- Views 189
- Downloads 0
Editorial Summary to the Special Edition on “Recent Advances in Pulmonary Rehabilitation”
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, and contributes substantially to annual healthcare expenditure. Key management strategies for people with COPD target symptom re...
Αlpha-1 Antitrypsin Gene Polymorphism in the Egyptian Population: Association with Obstructive Lung Diseases
Background: Given the potential adverse effects of asthma and Chronic Obstructive Pulmonary Disease (COPD), this study was undertaken to explore Alpha-1 Antitrypsin (AAT) polymorphism in the Egyptian population and its r...
Effectiveness of 5-Pyrrolidone-2-Carboxylic Acid and Copper Sulphate (Pirometaxine) in Cold Dry Air Induced Rhinitis With or Without Viral Superinfection
Introduction: Exposure to cold dry air can determine rhinitis-like symptoms. 5-Pyrrolidone-2-Carboxylic acid (PCA) and Copper Sulphate (CS) showed antiviral and osmoprotectant effect. Aim of this study is evaluation of e...
Is Mycoplasma Pneumoniae Infection Associated with Adult Asthma Exacerbation?
Mycoplasma pneumoniae infection has been considered as a cause of initial onset of bronchial asthma1 or exacerbation of asthma.2 For example, Kraft, et al. showed that M. pneumoniae was detected by Polymerase Chain React...
Serial Measurements of Tricuspid Regurgitation Pressure Gradient by Echocardiography Predict Prognosis in Idiopathic Pulmonary Fibrosis
Background and Objectives Idiopathic Pulmonary Fibrosis (IPF), especially with emphysema, reportedly involved with Pulmonary Hypertension (PH). However, it is not elucidated whether pulmonary arterial pressure changes se...